Healthcare & Life Sciences
Credo Therapies
United Kingdomwww.credotherapies.com
Credo Therapies is a Healthcare & Life Sciences startup based in the United Kingdom, most recent round Series C+, 1 tracked investor.
activeseries-c-plus
series-c-plus
Stage
2018
Founded
1
Investors
About Credo Therapies
Credo Therapies is a company founded in 2018 headquartered in the United Kingdom. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Credo Therapies delivers digitised psychotherapy for non-restrictive eating disorders through a clinically validated, tech-enabled platform built on Oxford university research.
Explore Credo Therapies's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.